AORTIC Cancer Genomics Conference – 18 &19 February 2021
Abstract Submissions open! Deadline 8 January 2021.
The African Organisation for Research and Training in Cancer (AORTIC) invites abstracts for its Inaugural Cancer Genomics in Africa Conference.
The conference will be convened under the theme “African Genomic Diversity: A Roadmap to Global Equity in Cancer Control”.
The scientific programme will feature a wide range of sessions with experts, researchers, and up-and-coming leaders in Genomics of Cancer in Africans,
on the Continent and in the African Diaspora.
This is an opportunity to share your research with African and international colleagues who are actively working in Cancer Genomics in Africa.
Abstracts of both empirical and theoretical studies related to genetics or genomics of cancers are welcome, and researchers at all career stages
are encouraged to submit one or more abstracts.
Abstracts will be peer reviewed. Acceptance will be based on content, available space, and overall Programme balance.
Abstracts should be relevant to Cancer Genomics in Africa. Abstracts must adequately describe the research performed to allow reviewers to
evaluate the quality, originality, and thoroughness of the work.
- Abstracts may be submitted in English, French, or Portuguese.
- Abstract title should be typed in UPPER CASE. The title should define the topic and contain no abbreviations.
- In the body of the abstract, standard abbreviations need not be defined; other abbreviations and acronyms should be defined on first use.
- Abstracts should contain four sections:
- OBJECTIVE: introductory sentence indicating the objective and purpose of the study.
- METHODS: description of experimental procedures, including applicable statistical evaluation.
- RESULTS: summary of the data and results.
- CONCLUSIONS: statement of the study’s conclusions.
- Generic names for pharmaceuticals, biologicals, and medical devices should be used in place of
Trade names. Trade names should only be used if equivalent products from multiple
manufacturers are being compared.
- Overly commercial abstracts will not be accepted.
- Do not include graphics, photographs, or tables.
- Maximum word count for the body of the abstract is 300 words.
- Submissions may have one presenting author and up to six co-authors.
- The submitting author must be the presenting author. The submitting author’s details must be entered first. All correspondence from the Programme Secretariat will be sent to submitting (presenting) author.
- The abstract will be listed under the submitting (presenting) author’s name in the conference programme and the electronic abstract publication.
- Abstracts must be submitted electronically via the Call for Abstract Submission site
- Authors of accepted abstracts will be invited to give an oral presentation or a poster presentation.
While effort will be made to accommodate the author’s preference in presentation format, the final decision will rest with the Scientific Programme Committee.
Researchers based in Africa will be given priority in the Oral Abstract sessions.
Authors chosen for a poster session will display their poster during a dedicated poster session.
All accepted abstracts will be published in the electronic abstract publication under the submitting (presenting) author’s name.
HOW TO SUBMIT AN ABSTRACT
- Prepare your abstract to the above specifications.
- Complete all compulsory fields and enter your abstract.
- Carefully check your personal and contact details and your abstract. Abstracts will be published “as is” with no editing.
- Check your email for your submission confirmation.
As the Submitting/Presenting author, you are the author to whom all correspondence will be sent.
As the Submitting/Presenting author, you are also required to attend the online sessions to present.
Abstracts will be filed by Submitting/Presenting author’s last name.
Enter in the details of each additional author. As the Submitting/Presenting author, your first and last name will automatically appear first.
Continue to add additional authors by clicking on Add Author. A maximum of 6 authors (including yourself) is permitted.
We look forward to receiving your abstracts!
For more about the AORTIC Cancer Genomics Conference please click here:
AORTIC African Cancer Leaders Institute (ACLI)
The goal of the AORTIC African Cancer Leaders Institute (ACLI) is to develop the next generation of leaders in cancer care, research, education, and advocacy in Africa. The ACLI supports and continues the 12th AORTIC conference theme of “Innovation, Strategies, Implement”.
The ACLI will develop activities for individuals who commit to provide leadership in cancer for Africa. The ACLI will commission workshops, satellite meetings, exchanges, and other activities to compliment the professional competencies of ACLI participants.
Examples of appropriate leadership skills to be developed include:
- Developing sustainable clinical practice, research and training initiatives, including funding mechanisms;
- Advocacy skills for collaboration with cancer researchers, patients, policy makers, Ministries of Health and other governmental bodies, and the public;
- Relationship management and development of partnerships with academic, governmental and non-governmental organizations;
- Strategic planning;
- Conflict management;
- Management of gender and ethnicity issues;
- Media relations and communication development and campaign management to improve understanding of cancer among the African public, policy makers, and others;
- Organizational management skills such as professional groups or cancer associations.
The ACLI was conceived as a “meeting within a meeting” and took place at the biennial AORTIC meeting. ACLI participants attended the regular AORTIC scientific sessions, but also participated in meeting sessions designed specifically for the ACLI, as well as meeting with mentors individually.
Following the start-up meeting, participants are expected to maintain contact with their mentors and other individuals on a regular basis, and report on activities they have engaged in as a result of their participation.
Goals and objectives for these activities are to be set and agreed in a kick-off session with their assigned mentor. The ACLI will form the basis of an African leadership network for cancer control in Africa, which itself will have annual goals and objectives set by the Executive committee of AORTIC.
Application and Selection Process
Solicitation will go to all AORTIC members. Applicants are selected by a committee appointed by the AORTIC Council based on their potential to develop as leaders in healthcare, research, community outreach, advocacy, governmental liaison, or other critical areas of need for cancer in Africa.
Potential to take on a future leadership role in AORTIC is a major criterion for selection.
BIG CAT (Beginning Investigator Grant for Catalytic Research)
The key objectives of the African Organization for Research and Training in Cancer (AORTIC) are to further research relating to cancers of relevance to Africa; to support training programs in oncology for health care workers and researchers, and to deal with the challenges of creating cancer control programs and to raise public awareness of cancer in Africa.
The U.S. National Cancer Institute (NCI) has been a long-standing supporter of AORTIC’s vision for enhancing cancer research and cancer control in Africa for the three (3) BIG Cat cohorts.
The Beginning Investigator Grant for Catalytic (BIG Cat) Research, a collaboration between AORTIC and NCI, is intended to support exploratory data collection by African scientists engaged in cancer research in Africa. The BIG Cat funding is not intended to support longer term research but to catalyze subsequent application for funding from NCI and/or other sources.
The grants are not intended for principal investigators outside of Africa, although collaborative research projects are encouraged. All funds provided must be spent in Africa. Research proposals are encouraged that span the cancer continuum (descriptive epidemiology, prevention, detection, diagnosis, and treatment including supportive and palliative care and behavioral research).
BIG Cat funding is intended to support research projects i.e., the funding is not intended to enhance or improve healthcare services directly but is for research aimed at forming a basis for reducing the burden of cancer in Africa.
The BIG CAT research funding is intended to support cancer research in Africa by African clinicians and scientists. The grant is $50 000 for a 2 year period.
To date BIG Cat Cohort I & II have been completed and we are currently finalizing BIG CAT Cohort III.